Psychological interventions for treatment of inflammatory bowel disease

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2008, Pages

  Timmer, Antje ^a   Jantschek, G ^b   Moser, G ^b   Motschall, E ^b   Preiss, J C ^b   Rucker, G ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COPING BEHAVIOR; DISEASE COURSE; ENTERITIS; HUMAN; OUTCOME ASSESSMENT; PATIENT EDUCATION; PSYCHODYNAMICS; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REMISSION; REVIEW;

EID: 44949128107     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006913     Document Type: Review

References (18)

1. Caprilli 2006 Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, et al.European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006;55(Suppl 1):i36-58.
2. D'Haens 2007 D'Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, et al.A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007;132(2):763-86.
3. Drossman 1989 Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI. Health-related quality of life in inflammatory bowel disease: Functional status and patient worries and concerns. Dig Dis Sci 1989;34(9):1379-86.
4. Farrokhyar 2006 Farrokhyar F, Marshall JK, Easterbrook B, Irvine EJ. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis 2006;12(1):38-46.
5. Higgins 2002 Higgins J, Thompson S, Deeks J, Altman D. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy 2002;7(1):51- 61.
6. Irvine 1994 Irvine EJ, Feagan BG, Rochon J, Archambault A, Fedorak RN, Groll A, et al.Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology 1994;106(2):287-96.
7. Levenstein 1993 Levenstein S, Prantera C, Varvo V, Scribano ML, Berto E, Luzi C, et al.Development of the Perceived Stress Questionnaire: a new tool for psychosomatic research. J Psychosom Res 1993;37(1):19-32.
8. Levenstein 2000 Levenstein S, Prantera C, Voarvo V, Scribano ML, Andreoli A, Luzi C, et al.Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol 2000;95(5):1213-20.
9. Mardini 2004 Mardini HE, Kip KE, Wilson JW. Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity. Dig Dis Sci 2004;49(3):492-7.
10. Mawdsley 2005 Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 2005;54(10):1481-91.
11. Mikocka-Walus 2006 Mikocka-Walus AA, Turnbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. Antidepressants and inflammatory bowel disease: a systematic review. Clin Pract Epidemol Ment Health 2006;2:24.
12. Mikocka-Walus 2007 Mikocka-Walus AA, Turnbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review. Inflamm Bowel Dis 2007;13(2):225-34.
13. Mittermaier 2004 Mittermaier C, Dejaco C, Waldhoer T, Öfferlbauer-Ernst A, Miehsler W, Beier M, et al.Impact of depressive mood on relapse in patients with inflammatory bowel diesease: a prospective 18-month follow-up study. Psychosom Med 2004;66(1):79-84.
14. Porcelli 1996 Porcelli P, Leoci C, Guerra V. A prospective study of the relationship between disease activity and psychologic distress in patients with inflammatory bowel disease. Scand J Gastroenterol 1996;31(8):792-6.
15. Sandborn 2002 Sandborn WJ, Feagan BG, Hanauer SB, Lochs H, Lofberg R, Modigliani R, et al.A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002;122(2):512-530.
16. Snaith 1986 Snaith RP, Zigmond AS. The hospital anxiety and depression scale. Br Med J (Clin Res Ed) 1986;292(6516):344.
17. von Wietersheim 2006 von Wietersheim J, Kessler H. Psychotherapy with chronic inflammatory bowel disease patients: a review. Inflamm Bowel Dis 2006;12(12):1175-84.
18. Ware 1995 Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995;33(4 Suppl):AS264-79.